Phio Pharmaceuticals Corp. · NASDAQ:PHIO
Phio Pharmaceuticals Corp. shareholders
As of Sep 30, 2026, 24 institutions reported holding Phio Pharmaceuticals Corp., 6.6% of its shares. Largest: Vanguard, Geode Capital and Two Sigma. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Phio Pharmaceuticals Corp. | Change | Filed |
|---|---|---|---|---|
| Vanguard | 170K | 1.4% | +37,944 | Nov 13, 2026 |
| Geode Capital | 106K | 0.88% | −8,888 | Nov 6, 2026 |
| Two Sigma | 68,416 | 0.57% | +46,915 | Nov 16, 2026 |
| Citadel | 65,686 | 0.55% | +18,536 | Nov 16, 2026 |
| Bridgeway Capital Management, LLC | 62,000 | 0.52% | +50,000 | Nov 16, 2026 |
| Jane Street | 61,446 | 0.51% | −56,309 | Nov 12, 2026 |
| Renaissance Technologies | 57,377 | 0.48% | new | Nov 12, 2026 |
| Nomura | 50,000 | 0.42% | no change | Nov 16, 2026 |
| Cetera Investment Advisers | 47,500 | 0.40% | no change | Nov 13, 2026 |
| XTX Topco Ltd | 27,821 | 0.23% | +9,346 | Nov 16, 2026 |